Price
$21.36
Increased by +2.45%
Dollar volume (20D)
21.64 M
ADR%
6.63
Earnings report date
Aug 8, 2024
Shares float
52.33 M
Shares short
8.48 M [16.22%]
Shares outstanding
93.41 M
Market cap
1.95 B
Beta
0.15
Price/earnings
N/A
20D range
16.52 23.50
50D range
15.87 23.50
200D range
5.12 23.50

Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders.

Its lead product candidate, EDG-5506, an orally administered small molecule that is in Phase II clinical trials, designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy.

The company develops EDG-7500, a small molecule for the treatment of hypertrophic cardiomyopathy and other severe cardiac disorders that is in Phase I clinical trials.

In addition, it develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders.

Edgewise Therapeutics, Inc. was incorporated in 2017 and is headquartered in Boulder, Colorado.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
May 9, 24 -0.33
Increased by +8.33%
-0.39
Increased by +15.38%
Feb 22, 24 -0.47
Decreased by -51.61%
-0.43
Decreased by -9.30%
Nov 9, 23 -0.41
Decreased by -20.59%
-0.40
Decreased by -2.50%
Aug 10, 23 -0.34
Decreased by -6.25%
-0.40
Increased by +15.00%
May 11, 23 -0.36
Decreased by -20.00%
-0.36
Feb 23, 23 -0.31
Decreased by -19.23%
-0.34
Increased by +8.82%
Nov 3, 22 -0.34
Decreased by -30.77%
-0.36
Increased by +5.56%
Aug 4, 22 -0.32
Decreased by -52.38%
-0.32
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Dec 31, 23 0.00
Decreased by N/A%
-30.14 M
Decreased by -79.95%
Decreased by N/A%
Decreased by N/A%
Sep 30, 23 0.00
Decreased by N/A%
-25.71 M
Decreased by -53.66%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by N/A%
-21.47 M
Decreased by -37.24%
Decreased by N/A%
Decreased by N/A%
Mar 31, 23 0.00
Decreased by N/A%
-19.73 M
Decreased by -36.13%
Decreased by N/A%
Decreased by N/A%
Dec 31, 22 0.00
Decreased by N/A%
-16.75 M
Decreased by -31.94%
Decreased by N/A%
Decreased by N/A%
Sep 30, 22 0.00
Decreased by N/A%
-16.73 M
Decreased by -29.23%
Decreased by N/A%
Decreased by N/A%
Jun 30, 22 0.00
Decreased by N/A%
-15.64 M
Decreased by -51.10%
Decreased by N/A%
Decreased by N/A%
Mar 31, 22 0.00
Decreased by N/A%
-14.49 M
Decreased by -112.68%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY